blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2294414

EP2294414 - ACTIVATION AND MONITORING OF CELLULAR TRANSMEMBRANE POTENTIALS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  22.07.2016
Database last updated on 03.10.2024
Most recent event   Tooltip17.08.2018Lapse of the patent in a contracting state
New state(s): BG		published on 19.09.2018  [2018/38]
Applicant(s)For all designated states
Life Technologies Corporation
5823 Newton Drive
Carlsbad, CA 92008 / US
[N/P]
Former [2015/38]For all designated states
Life Technologies Corporation
5791 Van Allen Way
Carlsbad, CA 92008 / US
Former [2011/11]For all designated states
Life Technologies Corporation
5791 Van Allen Way
Carlsbad, CA 92008 / US
Inventor(s)01 / IGNATIUS, Michael
3948 Blanton Road
Eugene Oregon 97405 / US
02 / MOLOKANOVA, Elena
2384 Panorama Drive
Eugene Oregon 97405 / US
03 / SAVTCHENKO, Alexei
2384 Panorama Drive
Eugene Oregon 97405 / US
04 / BARTEL, Joseph
3229 Blacktail Drive
Eugene Oregon 97405 / US
05 / ZHAO, Weiwen
2124 W. 16th Way
Eugene Oregon 97402 / US
06 / TREADWAY, Joseph
3280 Fillmore Street
Eugene Oregon 97405 / US
 [2011/11]
Representative(s)Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastraße 30
81925 München / DE
[2015/38]
Former [2012/13]HOFFMANN EITLE
Patent- und Rechtsanwälte Arabellastraße 4
81925 München / DE
Former [2012/11]Renken, Joachim, et al
Hoffmann - Eitle Patent- und Rechtsanwälte Arabellastrasse 4
81925 München / DE
Former [2011/11]Wöhler, Christian
Life Technologies Frankfurter Straße 129 B
DE-64293 Darmstadt / DE
Application number, filing date09773992.404.06.2009
[2011/11]
WO2009US46312
Priority number, dateUS20080059155P05.06.2008         Original published format: US 59155 P
[2011/11]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2010002540
Date:07.01.2010
Language:EN
[2010/01]
Type: A2 Application without search report 
No.:EP2294414
Date:16.03.2011
Language:EN
The application published by WIPO in one of the EPO official languages on 07.01.2010 takes the place of the publication of the European patent application.
[2011/11]
Type: B1 Patent specification 
No.:EP2294414
Date:16.09.2015
Language:EN
[2015/38]
Search report(s)International search report - published on:KR25.03.2010
(Supplementary) European search report - dispatched on:EP17.11.2011
ClassificationIPC:B82Y5/00, B82Y15/00, G01N33/58, G01N33/68
[2015/16]
CPC:
G01N33/6872 (EP,US); B82Y15/00 (EP,US); B82Y5/00 (EP,US);
G01N33/588 (EP,US); G01N2500/10 (EP,US)
Former IPC [2011/51]G01N33/50, G01N27/26, B82B3/00, G01N33/58, G01N33/68
Former IPC [2011/11]G01N33/50, G01N27/26, B82B3/00
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2015/38]
Former [2011/11]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:AKTIVIERUNG UND ÜBERWACHUNG VON ZELLTRANSMEMBRANPOTENTIALEN[2011/11]
English:ACTIVATION AND MONITORING OF CELLULAR TRANSMEMBRANE POTENTIALS[2011/11]
French:ACTIVATION ET CONTRÔLE DE POTENTIELS CELLULAIRES TRANSMEMBRANAIRES[2011/11]
Entry into regional phase23.12.2010National basic fee paid 
23.12.2010Search fee paid 
23.12.2010Designation fee(s) paid 
23.12.2010Examination fee paid 
Examination procedure23.12.2010Examination requested  [2011/11]
18.06.2012Amendment by applicant (claims and/or description)
31.07.2012Despatch of a communication from the examining division (Time limit: M06)
09.01.2013Reply to a communication from the examining division
28.01.2013Despatch of a communication from the examining division (Time limit: M04)
12.03.2013Reply to a communication from the examining division
02.04.2013Despatch of a communication from the examining division (Time limit: M04)
30.07.2013Reply to a communication from the examining division
23.09.2013Despatch of a communication from the examining division (Time limit: M04)
16.12.2013Reply to a communication from the examining division
22.04.2015Communication of intention to grant the patent
30.07.2015Fee for grant paid
30.07.2015Fee for publishing/printing paid
30.07.2015Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  31.07.2012
Opposition(s)17.06.2016No opposition filed within time limit [2016/34]
Fees paidRenewal fee
27.06.2011Renewal fee patent year 03
26.06.2012Renewal fee patent year 04
27.06.2013Renewal fee patent year 05
30.06.2014Renewal fee patent year 06
10.06.2015Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU04.06.2009
AT16.09.2015
BE16.09.2015
BG16.09.2015
CY16.09.2015
CZ16.09.2015
DK16.09.2015
EE16.09.2015
ES16.09.2015
FI16.09.2015
HR16.09.2015
IT16.09.2015
LT16.09.2015
LV16.09.2015
MC16.09.2015
MK16.09.2015
NL16.09.2015
PL16.09.2015
RO16.09.2015
SE16.09.2015
SI16.09.2015
SK16.09.2015
TR16.09.2015
NO16.12.2015
GR17.12.2015
IS16.01.2016
PT18.01.2016
IE04.06.2016
LU04.06.2016
[2018/38]
Former [2018/32]HU04.06.2009
AT16.09.2015
BE16.09.2015
CY16.09.2015
CZ16.09.2015
DK16.09.2015
EE16.09.2015
ES16.09.2015
FI16.09.2015
HR16.09.2015
IT16.09.2015
LT16.09.2015
LV16.09.2015
MC16.09.2015
MK16.09.2015
NL16.09.2015
PL16.09.2015
RO16.09.2015
SE16.09.2015
SI16.09.2015
SK16.09.2015
TR16.09.2015
NO16.12.2015
GR17.12.2015
IS16.01.2016
PT18.01.2016
IE04.06.2016
LU04.06.2016
Former [2018/29]HU04.06.2009
AT16.09.2015
BE16.09.2015
CY16.09.2015
CZ16.09.2015
DK16.09.2015
EE16.09.2015
ES16.09.2015
FI16.09.2015
HR16.09.2015
IT16.09.2015
LT16.09.2015
LV16.09.2015
MC16.09.2015
MK16.09.2015
NL16.09.2015
PL16.09.2015
RO16.09.2015
SE16.09.2015
SI16.09.2015
SK16.09.2015
TR16.09.2015
NO16.12.2015
GR17.12.2015
IS16.01.2016
PT18.01.2016
IE04.06.2016
LU04.06.2016
Former [2018/28]HU04.06.2009
AT16.09.2015
BE16.09.2015
CY16.09.2015
CZ16.09.2015
DK16.09.2015
EE16.09.2015
ES16.09.2015
FI16.09.2015
HR16.09.2015
IT16.09.2015
LT16.09.2015
LV16.09.2015
MC16.09.2015
MK16.09.2015
NL16.09.2015
PL16.09.2015
RO16.09.2015
SE16.09.2015
SI16.09.2015
SK16.09.2015
NO16.12.2015
GR17.12.2015
IS16.01.2016
PT18.01.2016
IE04.06.2016
Former [2017/38]AT16.09.2015
BE16.09.2015
CZ16.09.2015
DK16.09.2015
EE16.09.2015
ES16.09.2015
FI16.09.2015
HR16.09.2015
IT16.09.2015
LT16.09.2015
LV16.09.2015
MC16.09.2015
NL16.09.2015
PL16.09.2015
RO16.09.2015
SE16.09.2015
SI16.09.2015
SK16.09.2015
NO16.12.2015
GR17.12.2015
IS16.01.2016
PT18.01.2016
IE04.06.2016
Former [2017/07]AT16.09.2015
BE16.09.2015
CZ16.09.2015
DK16.09.2015
EE16.09.2015
ES16.09.2015
FI16.09.2015
HR16.09.2015
IT16.09.2015
LT16.09.2015
LV16.09.2015
MC16.09.2015
NL16.09.2015
PL16.09.2015
RO16.09.2015
SE16.09.2015
SI16.09.2015
SK16.09.2015
NO16.12.2015
GR17.12.2015
IS16.01.2016
PT18.01.2016
Former [2017/03]AT16.09.2015
BE16.09.2015
CZ16.09.2015
DK16.09.2015
EE16.09.2015
ES16.09.2015
FI16.09.2015
HR16.09.2015
IT16.09.2015
LT16.09.2015
LV16.09.2015
NL16.09.2015
PL16.09.2015
RO16.09.2015
SE16.09.2015
SI16.09.2015
SK16.09.2015
NO16.12.2015
GR17.12.2015
IS16.01.2016
PT18.01.2016
Former [2016/49]AT16.09.2015
CZ16.09.2015
DK16.09.2015
EE16.09.2015
ES16.09.2015
FI16.09.2015
HR16.09.2015
IT16.09.2015
LT16.09.2015
LV16.09.2015
NL16.09.2015
PL16.09.2015
RO16.09.2015
SE16.09.2015
SI16.09.2015
SK16.09.2015
NO16.12.2015
GR17.12.2015
IS16.01.2016
PT18.01.2016
Former [2016/39]AT16.09.2015
CZ16.09.2015
DK16.09.2015
EE16.09.2015
ES16.09.2015
FI16.09.2015
HR16.09.2015
IT16.09.2015
LT16.09.2015
LV16.09.2015
NL16.09.2015
PL16.09.2015
RO16.09.2015
SE16.09.2015
SK16.09.2015
NO16.12.2015
GR17.12.2015
IS16.01.2016
PT18.01.2016
Former [2016/24]AT16.09.2015
CZ16.09.2015
EE16.09.2015
ES16.09.2015
FI16.09.2015
HR16.09.2015
IT16.09.2015
LT16.09.2015
LV16.09.2015
NL16.09.2015
PL16.09.2015
RO16.09.2015
SE16.09.2015
SK16.09.2015
NO16.12.2015
GR17.12.2015
IS16.01.2016
PT18.01.2016
Former [2016/23]CZ16.09.2015
EE16.09.2015
ES16.09.2015
FI16.09.2015
HR16.09.2015
IT16.09.2015
LT16.09.2015
LV16.09.2015
NL16.09.2015
RO16.09.2015
SE16.09.2015
SK16.09.2015
NO16.12.2015
GR17.12.2015
IS16.01.2016
Former [2016/22]CZ16.09.2015
EE16.09.2015
ES16.09.2015
FI16.09.2015
HR16.09.2015
IT16.09.2015
LT16.09.2015
LV16.09.2015
NL16.09.2015
SE16.09.2015
NO16.12.2015
GR17.12.2015
IS16.01.2016
Former [2016/21]ES16.09.2015
FI16.09.2015
HR16.09.2015
IT16.09.2015
LT16.09.2015
LV16.09.2015
NL16.09.2015
SE16.09.2015
NO16.12.2015
GR17.12.2015
Former [2016/20]ES16.09.2015
FI16.09.2015
HR16.09.2015
LT16.09.2015
LV16.09.2015
NL16.09.2015
SE16.09.2015
NO16.12.2015
GR17.12.2015
Former [2016/14]FI16.09.2015
HR16.09.2015
LT16.09.2015
LV16.09.2015
NL16.09.2015
SE16.09.2015
NO16.12.2015
GR17.12.2015
Former [2016/11]FI16.09.2015
HR16.09.2015
LT16.09.2015
LV16.09.2015
SE16.09.2015
NO16.12.2015
GR17.12.2015
Former [2016/09]FI16.09.2015
LT16.09.2015
LV16.09.2015
NO16.12.2015
GR17.12.2015
Former [2016/08]LT16.09.2015
NO16.12.2015
Former [2016/07]LT16.09.2015
Documents cited:Search[X]  - MOLOKANOVA E ET AL, "Quantum dots move beyond fluorescence imaging", BIOPHOTONICS INTERNATIONAL JUNE 2008 LAURIN PUBLISHING CO. INC. US, (20080601), vol. 15, no. 6, pages 26 - 31, XP001526012 [X] 1-20 * the whole document *
 [X]  - MOLOKANOVA ET AL, "Bright future of optical assays for ion channel drug discovery", DRUG DISCOVERY TODAY, ELSEVIER, RAHWAY, NJ, US, (20080103), vol. 13, no. 1-2, doi:10.1016/J.DRUDIS.2007.11.009, ISSN 1359-6446, pages 14 - 22, XP022413776 [X] 1-20 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.drudis.2007.11.009
 [X]  - PAPPAS T C ET AL, "Nanoscale engineering of a cellular interface with semiconductor nanoparticle films for photoelectric stimulation of neurons", NANO LETTERS, ACS, WASHINGTON, DC, US, (20070201), vol. 7, no. 2, doi:10.1021/NL062513V, ISSN 1530-6984, pages 513 - 519, XP007908667 [X] 1-20 * the whole document *

DOI:   http://dx.doi.org/10.1021/nl062513v
International search[A]WO0159446  (CAMBRIDGE DRUG DISCOVERY LTD [GB], et al);
 [A]US2004110123  (MAHER MICHAEL P [US], et al);
 [X]WO2006096835  (MOLECULAR PROBES INC [US], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.